SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea · Delayed Price · Currency is KRW 847.00
0.00 (0.00%)
At close: Feb 19, 2026
SCM Lifescience Market Cap
SCM Lifescience has a market cap or net worth of 38.9 billion as of February 20, 2026. Its market cap has increased by 26.45% in one year.
Market Cap
38.90B
Enterprise Value
30.00B
Revenue
1.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
847.00
Market Cap Chart
Since June 17, 2020, SCM Lifescience's market cap has decreased from 398.06B to 38.90B, a decrease of -90.23%. That is a compound annual growth rate of -33.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 38.90B | -13.04% |
| Dec 30, 2025 | 44.73B | 15.58% |
| Dec 30, 2024 | 38.70B | -49.97% |
| Dec 28, 2023 | 77.37B | -55.83% |
| Dec 29, 2022 | 175.14B | -25.10% |
| Dec 30, 2021 | 233.83B | -60.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ark Solutions | 68.91B |
| SunBio,Inc. | 67.43B |
| EyeGene | 62.12B |
| NGeneBio | 57.46B |
| J2KBIO | 49.94B |
| Aptamer Sciences | 47.95B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |